Ensysce Biosciences, Inc.ENSCNASDAQ
Loading
Debt Growth Under PressureDecelerating
Percentile Rank38
Year-over-Year Change
Year-over-year debt growth rate
Percentile
P38
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -14.24% |
| Q2 2025 | 64.94% |
| Q1 2025 | -14.68% |
| Q4 2024 | -22.09% |
| Q3 2024 | -14.81% |
| Q2 2024 | 84.76% |
| Q1 2024 | -71.22% |
| Q4 2023 | 141.67% |
| Q3 2023 | -22.55% |
| Q2 2023 | 2288.41% |
| Q1 2023 | -99.57% |
| Q4 2022 | -50.60% |
| Q3 2022 | 236.50% |
| Q2 2022 | -65.26% |
| Q1 2022 | -55.40% |
| Q4 2021 | 248.23% |
| Q3 2021 | 937.95% |
| Q2 2021 | -90.27% |
| Q1 2021 | 14.59% |
| Q4 2020 | 654.16% |
| Q3 2020 | 0.00% |
| Q2 2020 | -63.85% |
| Q1 2020 | 176.59% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | -100.00% |
| Q3 2017 | 0.00% |